<p>温哥华，不列颠哥伦比亚省 --（Newsfile Corp. -2026 年 5 月 21 日）- Restart Life Sciences Corp.（CSE: HEAL）（FSE: HN30）（OTC Pink: NMLSF）（&#34;Restart Life&#34;或&#34;公司&#34;）很高兴地宣布，已成功完成其之前宣布的非承销私人配售（&#34;配售&#34;），向其全资子公司 Holy Crap Foods Inc.（&#34;Holy Crap&#34;）提供单位（&#34;单位&#34;）以建立循环采购订单（&#34;PO&#34;）融资来源。</p>
<p>公司共发行了 833,334 个单位，每个单位的价格为 0.12 加元，总毛收益为 100,000.08 加元（&#34;配售&#34;）。向关联方发行单位被视为根据《多边工具 61-101 - 保护特殊交易中的少数股东权益》（&#34;MI 61-101&#34;）的定义的关联交易。由于向这些人士发行的单位的公允市场价值不超过公司市值的 25%，公司依赖于 MI 61-101 的正式估值和少数股东批准要求的豁免。</p>
<p>为了直接支持公司的运营增长战略以及将 Holy Crap 推向美国市场，Restart Life 的首席执行官 Steve Loutskou 认购了配售的 50%（416,666 个单位）。</p>
<p>除了对循环 PO 基金的直接现金注入外，Loutskou 先生和其他公司内部人士通过公开市场的增持继续展示市场信心。</p>
<p>&#34;我坚决将我的资金投入其中，以确保我们的团队在进入北美夏季销售周期时不受阻碍，&#34; Restart Life 的首席执行官 Steve Loutskou 表示。&#34;通过选择自掏腰包资助</p>
<p>50%</p>
<p>这笔采购订单的配售，我在强化与股东的对齐。这项融资的结构故意设计得非常精简，以防止不必要的稀释，同时作为快速循环的资本工具。随着 Holy Crap 的订单量在批发、DTC、亚马逊和沃尔玛中持续增长，这些资金将立即解锁可扩展的生产能力。&#34;</p>
<p>正如公司在 2026 年 5 月 8 日的公告中详细说明的，配售的毛收益将作为专用的前期营运资金，用于制造和履行待处理的批发和电子商务采购订单。通过将生产资本隔离到一个循环池中，公司规避了传统的 60 到 180 天的零售收款滞后时间。一旦分销商的付款清算，资金将直接返回 PO 池，以立即为后续生产提供融资，保护核心企业财务。</p>
<p>每个在此次交易中发行的单位由一股普通股和一个可转让的普通股购买权证（&#34;权证&#34;）组成。每个权证赋予持有人在交易结束后两（2）年内以每股 0.15 加元的行使价格购买一股额外的普通股。</p>
<p>在此次配售的结束过程中没有支付中介费。根据适用的加拿大证券法，所有根据配售发行的证券均需遵守法定的四个月零一天的持有期，该持有期将于 2026 年 9 月 21 日到期。</p>
<p>Restart Life Sciences 感谢其股东的持续支持，因为公司在推进其使命并继续执行其战略。</p>
<p><strong>关于 Restart Life Sciences Corp.</strong> Restart Life Sciences Corp.是一家总部位于加拿大的生命科学公司，上市于 CSE。有关 Restart Life 的更多信息，请访问公司网站 www.restartlife.co。</p>
<p><strong>关于 Holy Crap Foods Inc.</strong> Holy Crap 超级种子谷物和 Holy Crap 超级种子燕麦片是提供营养丰富、清洁标签产品的优质功能性食品品牌，采用简单、高质量的成分。该品牌总部位于不列颠哥伦比亚省吉布森斯，凭借强大的消费者信任和重复购买，建立了忠诚且不断增长的客户基础。</p>
<p>Holy Crap 的无麸质、非转基因、高纤维产品定位于快速增长的肠道健康和保健类别，支持消化健康和持续能量，同时作为健康意识消费者的可信赖日常解决方案获得关注。有关更多信息，请访问 www.holycrap.com。</p>
<p><strong>代表董事会</strong> Steve Loutskou</p>
<p>首席执行官，Restart Life Sciences Corp. 电话：+1 (778) 819-0244</p>
<p>电子邮件：hello@restartlife.co</p>
<p><strong>前瞻性声明</strong> 本新闻稿包含构成&#34;前瞻性声明&#34;的陈述。这些前瞻性声明涉及已知和未知的风险、不确定性及其他因素，可能导致 Restart Life Sciences 的实际结果、表现或成就，或行业的发展与预期的结果、表现或成就存在重大差异。前瞻性声明是指不是历史事实的陈述，通常但不总是通过&#34;预计&#34;、&#34;计划&#34;、&#34;预期&#34;、&#34;相信&#34;、&#34;打算&#34;、&#34;估计&#34;、&#34;项目&#34;、&#34;潜在&#34;及类似表达来识别，或事件或条件&#34;将&#34;、&#34;会&#34;、&#34;可能&#34;、&#34;可以&#34;或&#34;应该&#34;发生。</p>
<p>加拿大证券交易所及其市场监管机构（根据加拿大证券交易所政策中的定义）对本公告的充分性或准确性不承担任何责任。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8801/298268_0ccd8c0e34e30a50_logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8801/298268_0ccd8c0e34e30a50_logo.jpg"/></p>
<p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/298268</p>
<p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/298268/375?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/298268/375"/></p>

<p>Restart Life Sciences Corp. 已完成一项非承销私人配售，发行了 833,334 个单位，每个单位价格为 0.12 加元，筹集了 100,000 加元。首席执行官 Steve Loutskou 认购了该配售的 50%，进一步表明他对公司增长战略的承诺。这笔资金将用于其子公司 Holy Crap Foods Inc. 的生产和订单履行，同时尽量减少稀释。每个单位包括一股普通股和一个未来购买的认股权证。所有证券均需遵守四个月的持有期</p>

<p>Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) (&#34;Restart Life&#34; or the &#34;Company&#34;) is pleased to announce that it has successfully closed its previously announced non-brokered private placement offering (the &#34;Offering&#34;) of units (the &#34;Units&#34;) to establish a revolving purchase order (&#34;PO&#34;) financing source for its wholly owned subsidiary, Holy Crap Foods Inc. (&#34;Holy Crap&#34;).</p>
<div class="lb-trans"><p>温哥华，不列颠哥伦比亚省 --（Newsfile Corp. -2026 年 5 月 21 日）- Restart Life Sciences Corp.（CSE: HEAL）（FSE: HN30）（OTC Pink: NMLSF）（&#34;Restart Life&#34;或&#34;公司&#34;）很高兴地宣布，已成功完成其之前宣布的非承销私人配售（&#34;配售&#34;），向其全资子公司 Holy Crap Foods Inc.（&#34;Holy Crap&#34;）提供单位（&#34;单位&#34;）以建立循环采购订单（&#34;PO&#34;）融资来源。</p>
</div><p>The Company has issued a total of 833,334 Units at a price of CAD $0.12 per Unit for aggregate gross proceeds of CAD $100,000.08 (the &#34;Offering&#34;). The issuance of Units to related parties is considered to be a related party transaction within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (&#34;MI 61-101&#34;). The Company has relied on the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of the Units issued to such persons does not exceed 25% of the Company's market capitalization.</p>
<div class="lb-trans"><p>公司共发行了 833,334 个单位，每个单位的价格为 0.12 加元，总毛收益为 100,000.08 加元（&#34;配售&#34;）。向关联方发行单位被视为根据《多边工具 61-101 - 保护特殊交易中的少数股东权益》（&#34;MI 61-101&#34;）的定义的关联交易。由于向这些人士发行的单位的公允市场价值不超过公司市值的 25%，公司依赖于 MI 61-101 的正式估值和少数股东批准要求的豁免。</p>
</div><p>Demonstrating direct commitment to the Company's operational growth strategy and the launch of Holy Crap into the United States market, Steve Loutskou, Chief Executive Officer of Restart Life, subscribed for 50% of the Offering (416,666 Units).</p>
<div class="lb-trans"><p>为了直接支持公司的运营增长战略以及将 Holy Crap 推向美国市场，Restart Life 的首席执行官 Steve Loutskou 认购了配售的 50%（416,666 个单位）。</p>
</div><p>In addition to this direct cash injection into the revolving PO fund, Mr. Loutskou and other corporate insiders have continued to demonstrate market confidence through open-market accumulations.</p>
<div class="lb-trans"><p>除了对循环 PO 基金的直接现金注入外，Loutskou 先生和其他公司内部人士通过公开市场的增持继续展示市场信心。</p>
</div><p>&#34;I am firmly putting my money where my mouth is to ensure our teams are unencumbered as we head into a North American summer sales cycle,&#34; said Steve Loutskou, CEO of Restart Life. &#34;By choosing to fund</p>
<div class="lb-trans"><p>&#34;我坚决将我的资金投入其中，以确保我们的团队在进入北美夏季销售周期时不受阻碍，&#34; Restart Life 的首席执行官 Steve Loutskou 表示。&#34;通过选择自掏腰包资助</p>
</div><p>50%</p>
<div class="lb-trans"><p>50%</p>
</div><p>of this purchase order placement out of my own pocket, I am reinforcing my alignment with our shareholders. This financing was intentionally structured to be exceptionally lean to prevent unnecessary dilution while serving as a rapid-recycling capital tool. As Holy Crap's order volume continues to grow with Wholesale, DTC, Amazon and Walmart, these funds will immediately unlock scalable production runs.&#34;</p>
<div class="lb-trans"><p>这笔采购订单的配售，我在强化与股东的对齐。这项融资的结构故意设计得非常精简，以防止不必要的稀释，同时作为快速循环的资本工具。随着 Holy Crap 的订单量在批发、DTC、亚马逊和沃尔玛中持续增长，这些资金将立即解锁可扩展的生产能力。&#34;</p>
</div><p>As detailed in the Company's announcement on May 8, 2026, the gross proceeds from the Offering will serve as dedicated upfront working capital to manufacture and fulfill pending wholesale and e-commerce purchase orders. By isolating production capital into a recycling pool, the Company circumvents traditional 60-to-180-day retail collection lag times. Once payments are cleared from distributors, funds return directly to the PO pool to instantly finance successive production runs, safeguarding the core corporate treasury.</p>
<div class="lb-trans"><p>正如公司在 2026 年 5 月 8 日的公告中详细说明的，配售的毛收益将作为专用的前期营运资金，用于制造和履行待处理的批发和电子商务采购订单。通过将生产资本隔离到一个循环池中，公司规避了传统的 60 到 180 天的零售收款滞后时间。一旦分销商的付款清算，资金将直接返回 PO 池，以立即为后续生产提供融资，保护核心企业财务。</p>
</div><p>Each Unit issued under the closing consists of one common share and one transferable common share purchase warrant (a &#34;Warrant&#34;). Each Warrant entitles the holder to purchase one additional common share for a period of two (2) years from the date of closing at an exercise price of CAD $0.15 per common share.</p>
<div class="lb-trans"><p>每个在此次交易中发行的单位由一股普通股和一个可转让的普通股购买权证（&#34;权证&#34;）组成。每个权证赋予持有人在交易结束后两（2）年内以每股 0.15 加元的行使价格购买一股额外的普通股。</p>
</div><p>No finder's fees were paid in connection with the closing of this Offering. All securities issued pursuant to the Offering are subject to a statutory four-month and one-day hold period expiring September 21, 2026, under applicable Canadian securities laws.</p>
<div class="lb-trans"><p>在此次配售的结束过程中没有支付中介费。根据适用的加拿大证券法，所有根据配售发行的证券均需遵守法定的四个月零一天的持有期，该持有期将于 2026 年 9 月 21 日到期。</p>
</div><p>Restart Life Sciences would like to thank its shareholders for their ongoing support as the Company advances its mission and continues to execute on its strategy.</p>
<div class="lb-trans"><p>Restart Life Sciences 感谢其股东的持续支持，因为公司在推进其使命并继续执行其战略。</p>
</div><p><strong>About Restart Life Sciences Corp.</strong> Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the CSE. For more information about Restart Life, please visit the Company's website at www.restartlife.co.</p>
<div class="lb-trans"><p><strong>关于 Restart Life Sciences Corp.</strong> Restart Life Sciences Corp.是一家总部位于加拿大的生命科学公司，上市于 CSE。有关 Restart Life 的更多信息，请访问公司网站 www.restartlife.co。</p>
</div><p><strong>About Holy Crap Foods Inc.</strong> Holy Crap Superseed Cereal and Holy Crap Superseed Oatmeal are premium functional food brands offering nutrient-dense, clean-label products made with simple, high-quality ingredients. Based in Gibsons, British Columbia, the brand has built a loyal and growing customer base across Canada, driven by strong consumer trust and repeat purchases.</p>
<div class="lb-trans"><p><strong>关于 Holy Crap Foods Inc.</strong> Holy Crap 超级种子谷物和 Holy Crap 超级种子燕麦片是提供营养丰富、清洁标签产品的优质功能性食品品牌，采用简单、高质量的成分。该品牌总部位于不列颠哥伦比亚省吉布森斯，凭借强大的消费者信任和重复购买，建立了忠诚且不断增长的客户基础。</p>
</div><p>Positioned within the fast-growing gut health and wellness category, Holy Crap's gluten-free, non-GMO, high-ﬁber products support digestive health and sustained energy, while gaining traction as a trusted, everyday solution for health-conscious consumers. For more information, visit www.holycrap.com</p>
<div class="lb-trans"><p>Holy Crap 的无麸质、非转基因、高纤维产品定位于快速增长的肠道健康和保健类别，支持消化健康和持续能量，同时作为健康意识消费者的可信赖日常解决方案获得关注。有关更多信息，请访问 www.holycrap.com。</p>
</div><p><strong>On behalf of the Board of Directors</strong> Steve Loutskou</p>
<div class="lb-trans"><p><strong>代表董事会</strong> Steve Loutskou</p>
</div><p>Chief Executive Ofﬁcer, Restart Life Sciences Corp. Tel: +1 (778) 819-0244</p>
<div class="lb-trans"><p>首席执行官，Restart Life Sciences Corp. 电话：+1 (778) 819-0244</p>
</div><p>Email: hello@restartlife.co</p>
<div class="lb-trans"><p>电子邮件：hello@restartlife.co</p>
</div><p><strong>Forward-Looking Statements</strong> This news release contains statements that constitute &#34;forward-looking statements.&#34; Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Restart Life Sciences' actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identiﬁed by the words &#34;expects,&#34; &#34;plans,&#34; &#34;anticipates,&#34; &#34;believes,&#34; &#34;intends,&#34; &#34;estimates,&#34; &#34;projects,&#34; &#34;potential&#34; and similar expressions, or that events or conditions &#34;will,&#34; &#34;would,&#34; &#34;may,&#34; &#34;could&#34; or &#34;should&#34; occur.</p>
<div class="lb-trans"><p><strong>前瞻性声明</strong> 本新闻稿包含构成&#34;前瞻性声明&#34;的陈述。这些前瞻性声明涉及已知和未知的风险、不确定性及其他因素，可能导致 Restart Life Sciences 的实际结果、表现或成就，或行业的发展与预期的结果、表现或成就存在重大差异。前瞻性声明是指不是历史事实的陈述，通常但不总是通过&#34;预计&#34;、&#34;计划&#34;、&#34;预期&#34;、&#34;相信&#34;、&#34;打算&#34;、&#34;估计&#34;、&#34;项目&#34;、&#34;潜在&#34;及类似表达来识别，或事件或条件&#34;将&#34;、&#34;会&#34;、&#34;可能&#34;、&#34;可以&#34;或&#34;应该&#34;发生。</p>
</div><p>Neither the Canadian Securities Exchange nor its Market Regulator (as that term is deﬁned in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.</p>
<div class="lb-trans"><p>加拿大证券交易所及其市场监管机构（根据加拿大证券交易所政策中的定义）对本公告的充分性或准确性不承担任何责任。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8801/298268_0ccd8c0e34e30a50_logo.jpg" alt="" original-src="https://images.newsfilecorp.com/files/8801/298268_0ccd8c0e34e30a50_logo.jpg"/></p>
<p>To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298268</p>
<div class="lb-trans"><p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/298268</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/298268/375" alt="" original-src="https://api.newsfilecorp.com/newsinfo/298268/375"/></p>

Restart Life Sciences 完成专用订单融资私募；首席执行官认购了 50% 的发行份额 | NMLSF 股票新闻